The National Institutes of Health requires an Institutional Biosafety Committee for any organization that receives federal funding to perform work with recombinant or synthetic nucleic molecules. The committee must approve all work with the following materials, and provide oversight to biosafety related research at Rutgers University. The Institutional Biosafety Committee reviews and approves all research at Rutgers University that falls into the following categories:

  • Recombinant and synthetic nucleic acids
  • Pathogenic Microorganisms (bacteria, viruses, parasites, fungi, etc. at BSL2 and higher)
  • Biological Toxins
  • Creation of a transgenic animal
  • Creation of a transgenic plant
  • Administration of rDNA to an animal or plant
  • Human Gene Therapy
  • Research with Human cells or human materials
  • Dual Use Research of Concern

The protocol form for the IBC is online at http://myrehs.rutgers.edu in the Biosafety Protocol Management System (BPMS).

For access to the BPMS, or for assistance with the IBC protocol form, please contact biosafety@rutgers.edu

Committee Roster

[Download PDF Roster]

Joan Durbin, M.D.,

Professor, Department of Pathology and Laboratory Medicine

New Jersey Medical School 

Chair, North Standing Committee

durbinje@njms.rutgers.edu

Ronald Hart, Ph.D.,

Professor, Department of Cell Biology and Neuroscience

Division of Life Sciences and Center for Collaborative Neuroscience

Chair, Central Standing Committee

rhart@rutgers.edu

The committee roster has been approved by the NIH Office of Science Policy and meets the requirements for the IBC composition as outlined in the NIH Guidelines.

Handbook

[Download PDF Handbook]

Meeting Dates and Minutes

The IBC meets as two standing committees on alternating months; one that reviews protocols for the northern Rutgers sites, and the other that reviews protocols for the central and southern sites. Protocols can be reviewed at either meeting. The dates and locations are listed below. Members can attend meetings at either location, and a conference call is usually arranged to facilitate such participation, or to allow for full committee discussion.

  • February 2, 2019
  • March 5, 2019
  • April 3, 2019
  • May 7, 2019
  • June 5, 2019
  • July 2, 2019
  • August 7, 2019
  • September 4, 2019
  • October 2, 2019
  • November 5, 2019
  • December 4, 2019

Meeting minutes are available upon request as required by the NIH Guidelines for Recombinant and Synthetic Nucleic Acids by emailing biosafety@rutgers.edu but will be redacted to protect security related information. Please contact the University Biosafety Officer with any questions.